Table 1.
Entry selection criteria of the treatment group (A) patients
| Patient | Age | Gender | CKD | Weight | Comorbidities | UACR | S. Creat. | Bl. Urea | e-GFR |
|---|---|---|---|---|---|---|---|---|---|
| No/G | Yrs | years | Kgm. | mg/g | mg/dl | mg/dl | ml/min. | ||
| 1/A | 40 | M | 6 | 77 | DM, HTN | 1135 | 3.1 | 122 | 30 |
| 2/A | 26 | F | 8 | 64 | DM, SLE, HTN | 1527 | 4.3 | 124 | 32 |
| 3/A | 35 | F | 5 | 62 | IN, HTN | 1542 | 3.5 | 125 | 32 |
| 4/A | 44 | F | 7 | 78 | IN, HTN | 1375 | 3.6 | 131 | 37 |
| 5/A | 26 | M | 9 | 63 | HTN | 1298 | 3.8 | 124 | 26 |
| 6/A | 37 | M | 8 | 65 | DM, HTN | 1273 | 3.1 | 122 | 29 |
| 7/A | 33 | F | 7 | 61 | DM, IN | 1722 | 4.1 | 143 | 26 |
| 8/A | 34 | F | 12 | 62 | IN, HTN | 1372 | 2.4 | 112 | 31 |
| 9/A | 28 | F | 7 | 69 | SLE, HTN | 1578 | 4.1 | 152 | 28 |
| 10/A | 30 | F | 8 | 60 | HTN | 1677 | 3.3 | 127 | 41 |
| 11/A | 29 | F | 9 | 62 | SLE, HTN | 1744 | 3.2 | 124 | 29 |
| 12/A | 40 | F | 13 | 59 | DM | 2133 | 2.8 | 113 | 34 |
| 13/A | 37 | M | 7 | 69 | DM, HTN | 1673 | 3.6 | 132 | 32 |
| 14/A | 35 | M | 15 | 61 | IN, HTN | 1273 | 3.8 | 148 | 37 |
| 15/A | 39 | M | 9 | 68 | DM | 1422 | 3.2 | 121 | 32 |
| 16/A | 41 | M | 6 | 59 | DM, HTN | 1566 | 2.6 | 117 | 34 |
| 17/A | 37 | M | 8 | 74 | DM | 1433 | 3.7 | 134 | 26 |
| 18/A | 28 | F | 12 | 63 | HTN | 2133 | 2.9 | 116 | 29 |
| 19/A | 34 | F | 9 | 68 | DM, IN | 1573 | 3.8 | 87 | 25 |
| 20/A | 28 | M | 11 | 77 | HTN | 1677 | 3.8 | 132 | 25 |
Mean age 32.154 ± 9.21year. 50% were males. The median body weight 66.05 ± 9.31 kgm. Seventy five percent (15/20) were hypertensive, fifty percent (10/20) were T1D, twenty five percent (5/20) were interstitial nephritis and fifteen percent (3/20) were systemic lupus erythematosus. (IN, interstitial nephritis; S. creat. Serum creatinine; DM, diabetes mellitus; HTN, hypertension; eGFR, estimated glomerular filtration rate)